CYP2C19Polymorphism and Proton Pump Inhibitors-Reference-Cited by-同舟云学术

CYP2C19Polymorphism and Proton Pump Inhibitors

Published:2004-07 Issue:1 Volume:95 Page:2-8
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:

Author:

Klotz Ulrich,Schwab Matthias,Treiber Gerhard

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.2004.pto950102.x/fullpdf

Reference54 articles.

1. Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P4502C19 poor metabolizers;Aoyama;J. Gastroenterol.,1999

2. Geographical/interracial differences in polymorphic drug oxidation;Bertilsson;Clin. Pharmacokinet.,1995

3. Identification and functional characterisation of new potentially defective alleles of human CYP2C19;Blaisdell;Pharmacogenetics,2002

4. Interphenotype differences in disposition and effect on gastrin levels of omeprazole - suitability of omeprazole as a probe for CYP2C19;Chang;Brit. J. Clin. Pharmacol.,1995

5. Pharmacogenetics of the proton pump inhibitors: a systematic review;Chong;Pharmacotherapy,2003

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-08-23

2. Basal gastric secretion as a prognostic criterion of proton pump inhibitors effectiveness;Reports of Vinnytsia National Medical University;2024-06-28

3. Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms;Clinical Pharmacology in Drug Development;2023-09-29

4. CYP2C19 genotypes and osteoporotic fractures in long‐term users of proton pump inhibitors: A hospital‐based study;Clinical and Translational Science;2023-09-05

5. Carcinogenicity assessment of tegoprazan in Sprague-Dawley (Crl:CD) rats and ICR (Crl:CD1) mice;Regulatory Toxicology and Pharmacology;2023-08